Zuranolone is the first oral drug specifically designed for severe depression after childbirth, with relief that starts on Day 3 of a two-week regimen, according to clinical trial results.
The new study, conducted by CAMH and the Institute for Clinical Evaluative Sciences, found that autistic females had an 83% increased risk of self-harm than non-autistic females.
Colleen Quinlan, the Saskatchewan Health Authority’s director of mental health and addictions, said in June that the centre will have two separate waiting rooms—one for those with mental health needs and the other for physical needs.
Diets high in saturated fat can cause neuro-inflammation responsible for depressive and anxiety disorders. The risk is increased when obesity is accompanied by metabolic dysfunctions.
A recent network meta-analysis investigated the mid- to long-term metabolic effects of antipsychotics in randomized controlled trials of 13 weeks’ duration or longer in patients with schizophrenia.
